drugset / Trial / NCT00048529

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

NCT00048529 ↗

Phase 2 Suspended 70 enrolled Tularik
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a clinical research study of T900607-sodium to determine if it is effective and safe in treating gastric cancer and adenocarcinoma of the esophagus. Patients will be treated on a weekly basis with an intravenous injection of the study drug.

Timeline

Start
2002-09
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject T900607 Small molecule — Intravenous